Alkermes plc. Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount
Alkermes plc. (ALKS) reported Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount of $4.84 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential · last filed 2025-02-12
- Alkermes plc. effective income tax rate reconciliation, foreign income tax rate differential, amount for fiscal 2024 was $4.84M, a 3.04% increase from fiscal 2023.
- Alkermes plc. effective income tax rate reconciliation, foreign income tax rate differential, amount for fiscal 2023 was $4.70M, a 802.30% increase from fiscal 2022.
- Alkermes plc. effective income tax rate reconciliation, foreign income tax rate differential, amount for fiscal 2022 was $521.00K, a 89.90% decline from fiscal 2021.
- Alkermes plc. effective income tax rate reconciliation, foreign income tax rate differential, amount for fiscal 2021 was $5.16M, a 33.84% decline from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount 9 month | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount 12 month | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount 12 month as first filed |
|---|---|---|---|
| 2024-12-31 | $4.84M 10-K · filed 2025-02-12 | ||
| 2023-12-31 | $4.70M 10-K · filed 2025-02-12 | ||
| 2022-12-31 | $521.00K 10-K · filed 2025-02-12 | -$2.12M 10-K · filed 2023-02-16 | |
| 2021-12-31 | $5.16M 10-K · filed 2024-02-21 | $5.81M 10-K · filed 2022-02-16 | |
| 2020-12-31 | $7.80M 10-K · filed 2023-02-16 | ||
| 2019-12-31 | $5.39M 10-K · filed 2022-02-16 | ||
| 2018-12-31 | $5.41M 10-K · filed 2021-02-11 | ||
| 2017-12-31 | -$682.00K 10-K · filed 2020-02-13 | ||
| 2016-12-31 | $2.72M 10-K · filed 2019-02-15 | ||
| 2015-12-31 | $13.95M 10-K · filed 2018-02-16 | ||
| 2014-12-31 | $28.60M 10-K · filed 2017-02-17 | ||
| 2013-12-31 | $11.28M 10-K · filed 2016-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |